LEADER 01114nam0-22003011i-450- 001 990001800610403321 005 20040225122036.0 035 $a000180061 035 $aFED01000180061 035 $a(Aleph)000180061FED01 035 $a000180061 100 $a20030910d1992----km-y0itay50------ba 101 0 $aita 200 1 $a<>metodo di misura degli stati di defogliazione delle chiome arboree mediante analisi quantitativa di immagini digitali$fGianfranco Scrinzi, Antonio Floris 210 $aVillazzano di Trento$cISAFA$d1992 215 $a31 p.$d30 cm 225 1 $aComunicazioni di ricerca$fIstituto sperimentale per l'assestamento forestale e per l'alpicoltura$v92-2 610 0 $aSelvicoltura 676 $a634.95 700 1$aScrinzi,$bGianfranco$078903 701 1$aFloris,$bAntonio$078907 801 0$aIT$bUNINA$gRICA$2UNIMARC 901 $aBK 912 $a990001800610403321 952 $a60 634.95 A 3/92-2$fFAGBC 959 $aFAGBC 996 $aMetodo di misura degli stati di defogliazione delle chiome arboree mediante analisi quantitativa di immagini digitali$9411372 997 $aUNINA LEADER 02242oam 2200445 a 450 001 9910696238803321 005 20071120162216.0 035 $a(CKB)5470000002376434 035 $a(OCoLC)173682812 035 $a(EXLCZ)995470000002376434 100 $a20071005d2007 ua 0 101 0 $aeng 135 $aurmn||||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aHigh-containment biosafety laboratories$b[electronic resource] $epreliminary observations on the oversight of the proliferation of BSL-3 and BSL-4 laboratories in the United States : testimony before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives /$fstatement of Keith Rhodes 210 1$a[Washington, D.C.] :$cU.S. Govt. Accountability Office,$d[2007] 215 $a35 pages $cdigital, PDF file 225 1 $aTestimony ;$vGAO-08-108 T 300 $aTitle from title screen (viewed on Oct. 5, 2007). 300 $a"For release on delivery...October 4, 2007." 300 $aPaper version available from: U.S. Govt. Accountability Office, 441 G St., NW, Rm. LM, Washington, D.C. 20548. 320 $aIncludes bibliographical references. 330 $aThis testimony addresses (1) the extent to which there has been a proliferation of BSL-3 and BSL-4 labs, (2) federal agencies' responsibility for tracking this proliferation and determining the associated risks, and (3) the lessons that can be learned from recent incidents at three high-containment biosafety labs. 517 $aHigh-containment biosafety laboratories 606 $aMicrobiological laboratories$zUnited States 606 $aMedical laboratories$zUnited States 615 0$aMicrobiological laboratories 615 0$aMedical laboratories 700 $aRhodes$b Keith A$01380699 712 02$aUnited States.$bCongress.$bHouse.$bCommittee on Energy and Commerce.$bSubcommittee on Oversight and Investigations. 712 02$aUnited States.$bGovernment Accountability Office. 801 0$bEJB 801 1$bEJB 801 2$bGPO 906 $aBOOK 912 $a9910696238803321 996 $aHigh-containment biosafety laboratories$93544174 997 $aUNINA